Tisotumab vedotin Interactions
There are 276 drugs known to interact with tisotumab vedotin. Of the total drug interactions, 63 are major, 201 are moderate, and 12 are minor.
Medications known to interact with tisotumab vedotin
Note: Showing generic names only.
A
- adalimumab
- adenovirus vaccine
- ado-trastuzumab emtansine
- alefacept
- alemtuzumab
- amiodarone
- amprenavir
- anakinra
- anthrax vaccine adsorbed
- apalutamide
- aprepitant
- atazanavir
- atorvastatin
- auranofin
- aurothioglucose
- azathioprine
B
- baricitinib
- bcg
- bcg vaccine
- benznidazole
- berotralstat
- bifidobacterium infantis
- boceprevir
- bortezomib
- brentuximab
- brewer's yeast
C
- cabazitaxel
- canakinumab
- candida albicans extract
- carbamazepine
- carboplatin
- carfilzomib
- ceritinib
- cerivastatin
- certolizumab
- chloramphenicol
- chloroquine
- cholera vaccine
- cholera vaccine, live
- ciprofloxacin
- cisplatin
- cladribine
- clarithromycin
- clozapine
- cobicistat
- coccidioidin skin test
- colchicine
- conivaptan
- crizotinib
D
- dapsone
- darunavir
- deferiprone
- delavirdine
- dengue vaccine
- denosumab
- didanosine
- diltiazem
- dimethyl fumarate
- dinutuximab
- diroximel fumarate
- disulfiram
- docetaxel
- dronedarone
- duvelisib
E
- efalizumab
- efgartigimod alfa
- eflapegrastim
- elotuzumab
- enfortumab vedotin
- enzalutamide
- eribulin
- erythromycin
- etanercept
- ethambutol
- ethionamide
- etoposide
- etravirine
F
- fedratinib
- fexinidazole
- filgrastim
- fingolimod
- fluconazole
- fludarabine
- fluvastatin
- fluvoxamine
- fosamprenavir
- fosaprepitant
- fosphenytoin
G
H
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- histoplasmin
- human papillomavirus vaccine
- hydralazine
- hydroxychloroquine
I
- idelalisib
- imatinib
- indinavir
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live, trivalent
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- iodoquinol
- ipilimumab
- isavuconazonium
- isoniazid
- itraconazole
- ixabepilone
- ixazomib
J
K
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- leflunomide
- letermovir
- levodopa
- levoketoconazole
- linezolid
- lonafarnib
- lovastatin
- lyme disease vaccine
M
- measles virus vaccine
- meningococcal conjugate vaccine
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- metronidazole
- mibefradil
- mifepristone
- mirvetuximab soravtansine
- mitotane
- mixed respiratory vaccine
- monomethyl fumarate
- mumps skin test antigen
- mumps virus vaccine
N
O
P
- paclitaxel
- paclitaxel protein-bound
- pegfilgrastim
- peginterferon alfa-2a
- peginterferon alfa-2b
- phenobarbital
- phenytoin
- pitavastatin
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- polatuzumab vedotin
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- pomalidomide
- ponatinib
- ponesimod
- posaconazole
- pravastatin
- primidone
R
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- radium 223 dichloride
- red yeast rice
- ribociclib
- rifabutin
- rifampin
- rifapentine
- rilonacept
- ritonavir
- roflumilast
- ropeginterferon alfa-2b
- rosuvastatin
- rotavirus vaccine
- rubella virus vaccine
S
- saccharomyces boulardii lyo
- samarium sm 153 lexidronam
- saquinavir
- sargramostim
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna (tozinameran 12y+) bivalent booster vaccine
- sars-cov-2 (covid-19) mrna (tozinameran 5y-11y) bivalent booster vaccine
- sars-cov-2 (covid-19) mrna (tozinameran 6m-4y) bivalent booster vaccine
- sars-cov-2 (covid-19) mrna-1273 (6m-5y bivalent booster) vaccine
- sars-cov-2 (covid-19) mrna-1273 (bivalent booster) vaccine
- sars-cov-2 (covid-19) mrna-1273 vaccine
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 (covid-19)mrna-1273(6y+ bivalent booster) vaccine
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- secnidazole
- selinexor
- simvastatin
- siponimod
- sipuleucel-T
- skin test antigens, multiple
- smallpox and monkeypox vaccine
- smallpox vaccine
- sodium phosphate p32
- st. john's wort
- staphage lysate (spl)
- stavudine
- strontium-89 chloride
T
- talimogene laherparepvec
- tbo-filgrastim
- teclistamab
- telaprevir
- telbivudine
- telithromycin
- teniposide
- teriflunomide
- tetanus toxoid
- thalidomide
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tinidazole
- tocilizumab
- tofacitinib
- topotecan
- trabectedin
- trichophyton skin test
- troleandomycin
- tuberculin purified protein derivative
- tucatinib
- typhoid vaccine, inactivated
- typhoid vaccine, live
U
V
- valganciclovir
- varicella virus vaccine
- verapamil
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- voclosporin
- voriconazole
- voxelotor
Y
Z
More about tisotumab vedotin
- tisotumab vedotin consumer information
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.